Cancer Therapeutics and Biotherapeutics Market Expands Rapidly, Poised for US$ 417.2 Billion Value Global Cancer Therapeutics and Biotherapeutics Market size is expected to be worth around US$ 417.2 billion by 2034 from US$ 184.5 billion in 2024, growing at a CAGR of 8.5% during the forecast period 2025 to 2034. In 2023, North America led the market, achieving over 41.6% share with a revenue of US$ 76.8 Billion. https://market.us/report/cancer-therapeutics-and-biotherapeutics-market/

Fibrosis Therapy AI drug research company pioneering anti-cancer therapeutics, anti-fibrosis small molecule drugs, Smad/Smad3 inhibition, and combination cancer-fibrosis therapies About Company- Moexa is an early stage multi-national drug research and development company with proprietary TGF-β/Smad3, AI designed, small molecule anti-cancer and anti-fibrosis therapeutic. Moexa's SMAD3 TGF-β prevents cancer and fibrosis. Click Here For More Info:- https://moexa.com/ Social Media Profile Links:- https://www.linkedin.com/company/moexa/?originalSubdomain=hk